A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 ‘CREATE’ trial

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

Public Health, Biostatistics, Experimental Design +10

First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer

Benjamin Solomon, Tony Mok, Dong‐Wan Kim et al. · New England Journal of Medicine · 2014 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +12

Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations

David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +12

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

New England Journal of Medicine · 2015 · 1.4K citations · Full text

Medicine, Molecular Genetics, Oncology +17

Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions

Christine M. Lovly, Abha A. Gupta, Doron Lipson et al. · Cancer Discovery · 2014 · 452 citations · Full text

Medicine, Molecular Genetics, Oncology +17